Comparison of Intravascular Ultrasound With Venography in the Diagnosis and Treatment of Iliac Vein Compression Syndrome

NCT ID: NCT03309969

Last Updated: 2017-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-30

Study Completion Date

2019-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare intravascular ultrasound with venography in the diagnosis and treatment of iliac vein compression syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iliac Vein Compression Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

observation group

Subjects with suspicious iliac vein compression syndrome were included in the observation group.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18 to 90 years
* Willing to participate in and sign the informed consent
* Patients with suspicious iliac vein stenosis or compression presented by preoperative magnetic resonance venography (MRV)
* Patent common femoral vein and/or femoral vein of the study leg
* Undergoing iliofemoral venography with the intend to treat potential iliac vein compression syndrome

Exclusion Criteria

* Not providing informed consent
* Venous compression caused by pelvic tumors or fibroid uterus
* Previous stent implantation or venovenous bypass surgery of the study leg
* Known metal allergy precluding the possibility of stent implantation
* Known iodine allergy or severe renal insufficient function which are unsuitable for venography
* Pregnant or planning to be pregnant recently
* Acute deep vein thrombosis or tumor thrombus involving the study leg
* Know history of thrombophilia (e.g. protein C or S deficiency, anti-thrombin III deficiency, etc )
* Any concurrent disease, for example, heart failure, might make the patients unsuitable for surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Zhongshan Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

180 Fenglin Road

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhenyu Shi, Doctor

Role: CONTACT

Phone: +86 18616880807

Email: [email protected]

Yong Ding, Master

Role: CONTACT

Phone: +86 18702171713

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhenyu Shi, doctor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B2017-115

Identifier Type: -

Identifier Source: org_study_id